Page 35 - Pharma

Endo's arm Par Pharma engages Granules India to market OTC drug in US

Granules USA, the wholly-owned subsidiary of the Hyderabad-based firm, will market Par Pharma's generic version of OTC omeprazole and sodium bicarbonate drug in USA

UN-backed Medicines Patent Pool licences hepatitis C drug to four Indian companies

Cipla, Emcure, Hetero and Natco have signed agreement for producing & selling daclatasvir, an HCV drug, with Bristol-Myers Squibb (the patent holder) and the MPP in 112 countries

Clariant begins construction work on packaging plant in Cuddalore

Plant, built with an investment of about Rs 65 crore and expected to be operational by 2017, will produce moisture-control solutions for pharmaceutical packaging industry

Autoline forays into auto accessories, hospital equipment sectors

The company is also exploring business opportunities in railways and defence sectors

Govt hikes basic customs duty on medical devices

The move is aimed at promoting domestic manufacturing of medical devices, in line with the government's Make in India campaign

Celestial Biolabs to venture into allopathic medicines

The company plans to manufacture 21 lifesaving drugs in allopathic range

UAE's Abraaj Group buys majority stake in Care Hospitals

Abraaj bought stakes in the hospital chain from global PE firm Advent International

Counterfeits to hurt India's manufacturing sector: A report

Illicit market in seven select manufacturing sectors led to a loss of Rs 39,239 crore during 2014, says a FICCI report

National IPR policy to boost economic growth: Ram Vilas Paswan

Enforcement of IP rights in India will become increasingly important to prospective overseas investors, according to the Ministry

Aurobindo Pharma receives US FDA's nod for tranexamic acid and paricalcitol

Tranexamic acid injection and paricalcitol capsule are generic versions of Pharmacia and Upjohn Company's Cyklokapron and Abbvie's Zemplar, respectively

Lonza expands mammalian manufacturing capacity in UK

The company has added two 1000L single-use bioreactor systems to its current mammalian manufacturing capacity

Centre to set up 6 pharma and 2 medical devices parks

New parks entails investment of about Rs 30,000 crores, says Ananth Kumar while releasing the report of task force set up for the development of pharmaceutical industry

HPCL-Gail to set up a petrochemical complex in AP

Ananth Kumar at CII Partnership Summit 2016 announced a slew of new projects, which included a petrochemical complex, medical devices manufacturing cluster, etc in Andhra Pradesh

Torrent Pharma launches biosimilar of auto immune drug adalimumab

Adfrar, the brand name of the drug, will be the second biosimilar adalimumab in the world

Gavi to provide $ 500 mn to fund vaccination program in India

The global healthcare NGO will use the fund to accelerate the introduction of modern and highly effective childhood vaccines for all children in India

Sanofi collaborates Warp Drive Bio to develop oncology therapies and antibiotics

Under the terms of the agreement, new collaboration will provide Warp Drive funding and milestones in excess of $750 million

Novartis ties up with Surface Oncology to grow immuno-oncology pipeline

Agreement gives Novartis access to four pre-clinical programs that target regulatory T cell populations, inhibitory cytokines, and immunosuppressive metabolites in the tumour microenvironment

US FDA approves Aurobindo Pharma's norethindrone tablet

The approved product, a generic version of Duramed's Aygestin tablet, has an estimated market size of $ 24 million, according to IMS

Shire buys Baxalta in $32-bn deal

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020

Celanese to expand Gur UHMWPE capacity in Texas

This capacity expansion provides Celanese with additional production flexibility to introduce two new medical Gur grades for the pharmaceutical industry